600196 Shanghai Fosun Pharmaceutical
- 23.18
- -0.12-0.52%
Shanghai Fosun Pharmaceutical News
Announcement of Fosun Pharmaceutical on sale of some transactional financial assets
Fosun Pharmaceutical: Fosun Pharmaceutical's announcement on the acceptance of the Company's medium-term note registration by the China Interbank Market Dealers Association
Announcement of Fosun Pharmaceutical on the acceptance of the registration of the Company's medium-term notes by the China Interbank Market Dealers Association
Fosun Pharmaceutical: Fosun Pharmaceutical's announcement on the acceptance of the registration of the Company's ultra-short-term financing notes by the China Interbank Market Dealers Association
Announcement of Fosun Pharmaceutical on the acceptance of the registration of the Company's ultra-short-term financing notes by the China Interbank Market Dealers Association
Fosun Pharmaceutical: Announcement on sale of assets and related transactions by Fosun Pharmaceutical
Fosun Pharmaceutical: Fosun Pharmaceutical's 2021 A-share equity allocation implementation announcement
Fosun Pharmaceutical's 2021 A-share equity distribution implementation announcement
Fosun Pharmaceutical: Fosun Pharmaceutical's announcement on the completion of the issuance of the first instalment of ultra-short-term financing notes in 2022
Fosun Pharmaceutical's announcement on the completion of the issuance of the first instalment of ultra-short-term financing notes in 2022
Fosun Pharmaceutical: Announcement of Fosun Pharmaceutical's 2021 Profit Distribution Plan
Fosun Pharmaceutical: Fosun Pharmaceutical\'s announcement on the completion of the issuance of the first issue of 2022 interim notes
Fosun Pharmaceutical's announcement on the completion of the issuance of the first issue of 2022 interim notes
Fosun Pharmaceutical: Fosun Pharmaceutical's announcement on the completion of the issuance of the third instalment of ultra-short-term financing notes in 2021
Fosun Pharmaceutical: Announcement on the progress of Fosun Pharmaceutical's sale of assets and related transactions
Fosun Pharmaceutical: Fosun Pharmaceutical\'s announcement on the completion of the issuance of the second instalment of ultra-short-term financing notes in 2021
Fosun Pharmaceutical: Fosun Pharmaceutical's announcement on the completion of the issuance of the first instalment of ultra-short-term financing notes in 2021
Fosun Pharmaceutical: Notice on the acceptance of the registration of the Company's medium-term notes by the China Interbank Market Dealers Association
Fosun Pharmaceutical: Notice on the acceptance by the China Interbank Market Dealers Association of the Company's ultra-short-term financing notes
Fosun Pharmaceuticals: Follow-up rating reports for 16 compounding drugs 01, 17 compounding drugs 01, 18 compounding drugs 01, 18 combos 02 and 18 combos 03
Analysis
Price Target
No Data
